APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cyproheptadine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cyproheptadine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchCyproheptadine Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyproheptadine Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Cyproheptadine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyproheptadine Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyproheptadine Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Cyproheptadine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cyproheptadine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cyproheptadine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyproheptadine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cyproheptadine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cyproheptadine include MSD, Abbott, Teva, Novartis, Teriak, Royal Pharma, Qualipharm, Pharma Arte and Panbiotic Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cyproheptadine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cyproheptadine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cyproheptadine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cyproheptadine market size, projected growth trends, production technologies, key applications, and end-use industries.

Cyproheptadine Segment by Company

MSD

Abbott

Teva

Novartis

Teriak

Royal Pharma

Qualipharm

Pharma Arte

Panbiotic Laboratories

Nichi-Iko Pharmaceutical

Medphano

Laboratoires Servier

Kalbe

General Pharma

Fu Yuan Pharmaceutical

Faes Pharma

Cipla Medpro South Africa

Caillon and Hamonet

Arena Pharmaceuticals

Apex Pharma

Allena Pharmaceuticals

Aero-Chem

Cyproheptadine Segment by Type

Patent

Generic

Cyproheptadine Segment by Application

On-line

Drug Store

Hospital

Cyproheptadine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyproheptadine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyproheptadine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyproheptadine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cyproheptadine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cyproheptadine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cyproheptadine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cyproheptadine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cyproheptadine Industry Trends Table 2. Cyproheptadine Industry Drivers Table 3. Cyproheptadine Industry Opportunities and Challenges Table 4. Cyproheptadine Industry Restraints Table 5. Global Cyproheptadine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cyproheptadine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cyproheptadine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Cyproheptadine Sales Market Share by Manufacturers Table 9. Global Cyproheptadine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cyproheptadine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cyproheptadine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cyproheptadine Manufacturers, Product Type & Application Table 13. Global Cyproheptadine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cyproheptadine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Patent Table 17. Major Manufacturers of Generic Table 18. Global Cyproheptadine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Cyproheptadine Sales by Type (2021-2026) & (K Units) Table 20. Global Cyproheptadine Sales by Type (2027-2032) & (K Units) Table 21. Global Cyproheptadine Sales Market Share by Type (2021-2026) Table 22. Global Cyproheptadine Sales Market Share by Type (2027-2032) Table 23. Global Cyproheptadine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Cyproheptadine Revenue by Type (2021-2026) & (K Units) Table 25. Global Cyproheptadine Revenue by Type (2027-2032) & (K Units) Table 26. Global Cyproheptadine Revenue Market Share by Type (2021-2026) Table 27. Global Cyproheptadine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of On-line Table 29. Major Manufacturers of Drug Store Table 30. Major Manufacturers of Hospital Table 31. Global Cyproheptadine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Cyproheptadine Sales by Application (2021-2026) & (K Units) Table 33. Global Cyproheptadine Sales by Application (2027-2032) & (K Units) Table 34. Global Cyproheptadine Sales Market Share by Application (2021-2026) Table 35. Global Cyproheptadine Sales Market Share by Application (2027-2032) Table 36. Global Cyproheptadine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Cyproheptadine Revenue by Application (2021-2026) & (K Units) Table 38. Global Cyproheptadine Revenue by Application (2027-2032) & (K Units) Table 39. Global Cyproheptadine Revenue Market Share by Application (2021-2026) Table 40. Global Cyproheptadine Revenue Market Share by Application (2027-2032) Table 41. Global Cyproheptadine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Cyproheptadine Sales by Region (2021-2026) & (K Units) Table 43. Global Cyproheptadine Sales Market Share by Region (2021-2026) Table 44. Global Cyproheptadine Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Cyproheptadine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Cyproheptadine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Cyproheptadine Sales by Country (2021-2026) & (K Units) Table 48. North America Cyproheptadine Sales by Country (2027-2032) & (K Units) Table 49. Europe Cyproheptadine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Cyproheptadine Sales by Country (2021-2026) & (K Units) Table 51. Europe Cyproheptadine Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Cyproheptadine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Cyproheptadine Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Cyproheptadine Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Cyproheptadine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Cyproheptadine Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Cyproheptadine Sales by Country (2027-2032) & (K Units) Table 58. Global Cyproheptadine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Cyproheptadine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Cyproheptadine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Cyproheptadine Revenue Market Share by Region (2021-2026) Table 62. Global Cyproheptadine Revenue Market Share by Region (2027-2032) Table 63. MSD Company Information Table 64. MSD Business Overview Table 65. MSD Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. MSD Cyproheptadine Product Portfolio Table 67. MSD Recent Development Table 68. Abbott Company Information Table 69. Abbott Business Overview Table 70. Abbott Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Abbott Cyproheptadine Product Portfolio Table 72. Abbott Recent Development Table 73. Teva Company Information Table 74. Teva Business Overview Table 75. Teva Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Teva Cyproheptadine Product Portfolio Table 77. Teva Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Novartis Cyproheptadine Product Portfolio Table 82. Novartis Recent Development Table 83. Teriak Company Information Table 84. Teriak Business Overview Table 85. Teriak Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Teriak Cyproheptadine Product Portfolio Table 87. Teriak Recent Development Table 88. Royal Pharma Company Information Table 89. Royal Pharma Business Overview Table 90. Royal Pharma Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Royal Pharma Cyproheptadine Product Portfolio Table 92. Royal Pharma Recent Development Table 93. Qualipharm Company Information Table 94. Qualipharm Business Overview Table 95. Qualipharm Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Qualipharm Cyproheptadine Product Portfolio Table 97. Qualipharm Recent Development Table 98. Pharma Arte Company Information Table 99. Pharma Arte Business Overview Table 100. Pharma Arte Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Pharma Arte Cyproheptadine Product Portfolio Table 102. Pharma Arte Recent Development Table 103. Panbiotic Laboratories Company Information Table 104. Panbiotic Laboratories Business Overview Table 105. Panbiotic Laboratories Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Panbiotic Laboratories Cyproheptadine Product Portfolio Table 107. Panbiotic Laboratories Recent Development Table 108. Nichi-Iko Pharmaceutical Company Information Table 109. Nichi-Iko Pharmaceutical Business Overview Table 110. Nichi-Iko Pharmaceutical Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Nichi-Iko Pharmaceutical Cyproheptadine Product Portfolio Table 112. Nichi-Iko Pharmaceutical Recent Development Table 113. Medphano Company Information Table 114. Medphano Business Overview Table 115. Medphano Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Medphano Cyproheptadine Product Portfolio Table 117. Medphano Recent Development Table 118. Laboratoires Servier Company Information Table 119. Laboratoires Servier Business Overview Table 120. Laboratoires Servier Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Laboratoires Servier Cyproheptadine Product Portfolio Table 122. Laboratoires Servier Recent Development Table 123. Kalbe Company Information Table 124. Kalbe Business Overview Table 125. Kalbe Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Kalbe Cyproheptadine Product Portfolio Table 127. Kalbe Recent Development Table 128. General Pharma Company Information Table 129. General Pharma Business Overview Table 130. General Pharma Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. General Pharma Cyproheptadine Product Portfolio Table 132. General Pharma Recent Development Table 133. Fu Yuan Pharmaceutical Company Information Table 134. Fu Yuan Pharmaceutical Business Overview Table 135. Fu Yuan Pharmaceutical Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Fu Yuan Pharmaceutical Cyproheptadine Product Portfolio Table 137. Fu Yuan Pharmaceutical Recent Development Table 138. Faes Pharma Company Information Table 139. Faes Pharma Business Overview Table 140. Faes Pharma Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Faes Pharma Cyproheptadine Product Portfolio Table 142. Faes Pharma Recent Development Table 143. Cipla Medpro South Africa Company Information Table 144. Cipla Medpro South Africa Business Overview Table 145. Cipla Medpro South Africa Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Cipla Medpro South Africa Cyproheptadine Product Portfolio Table 147. Cipla Medpro South Africa Recent Development Table 148. Caillon and Hamonet Company Information Table 149. Caillon and Hamonet Business Overview Table 150. Caillon and Hamonet Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Caillon and Hamonet Cyproheptadine Product Portfolio Table 152. Caillon and Hamonet Recent Development Table 153. Arena Pharmaceuticals Company Information Table 154. Arena Pharmaceuticals Business Overview Table 155. Arena Pharmaceuticals Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Arena Pharmaceuticals Cyproheptadine Product Portfolio Table 157. Arena Pharmaceuticals Recent Development Table 158. Apex Pharma Company Information Table 159. Apex Pharma Business Overview Table 160. Apex Pharma Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Apex Pharma Cyproheptadine Product Portfolio Table 162. Apex Pharma Recent Development Table 163. Allena Pharmaceuticals Company Information Table 164. Allena Pharmaceuticals Business Overview Table 165. Allena Pharmaceuticals Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Allena Pharmaceuticals Cyproheptadine Product Portfolio Table 167. Allena Pharmaceuticals Recent Development Table 168. Aero-Chem Company Information Table 169. Aero-Chem Business Overview Table 170. Aero-Chem Cyproheptadine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Aero-Chem Cyproheptadine Product Portfolio Table 172. Aero-Chem Recent Development Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Cyproheptadine Distributors List Table 176. Cyproheptadine Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Cyproheptadine Product Image Figure 2. Global Cyproheptadine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyproheptadine Market Size (2021-2032) & (US$ Million) Figure 4. Global Cyproheptadine Sales (2021-2032) & (K Units) Figure 5. Global Cyproheptadine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cyproheptadine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Patent Image Figure 9. Generic Image Figure 10. Global Cyproheptadine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Cyproheptadine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Cyproheptadine Sales Market Share by Type (2021-2032) Figure 13. Global Cyproheptadine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Cyproheptadine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Cyproheptadine Revenue Market Share by Type (2021-2032) Figure 16. On-line Image Figure 17. Drug Store Image Figure 18. Hospital Image Figure 19. Global Cyproheptadine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Cyproheptadine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Cyproheptadine Sales Market Share by Application (2021-2032) Figure 22. Global Cyproheptadine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Cyproheptadine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Cyproheptadine Revenue Market Share by Application (2021-2032) Figure 25. North America Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Cyproheptadine Sales Market Share by Country (2021-2032) Figure 27. U.S. Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Cyproheptadine Sales Market Share by Country (2021-2032) Figure 32. Germany Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Cyproheptadine Sales Market Share by Country (2021-2032) Figure 39. China Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Cyproheptadine Sales Market Share by Country (2021-2032) Figure 47. Brazil Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Cyproheptadine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Cyproheptadine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Cyproheptadine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Cyproheptadine Revenue (2021-2032) & (US$ Million) Figure 58. North America Cyproheptadine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Cyproheptadine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Cyproheptadine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Cyproheptadine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Cyproheptadine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Cyproheptadine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Cyproheptadine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Cyproheptadine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Cyproheptadine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Patent
  • Generic
Applications
  • On-line
  • Drug Store
  • Hospital
Companies covered
  • MSD
  • Abbott
  • Teva
  • Novartis
  • Teriak
  • Royal Pharma
  • Qualipharm
  • Pharma Arte
  • Panbiotic Laboratories
  • Nichi-Iko Pharmaceutical
  • Medphano
  • Laboratoires Servier
  • Kalbe
  • General Pharma
  • Fu Yuan Pharmaceutical
  • Faes Pharma
  • Cipla Medpro South Africa
  • Caillon and Hamonet
  • Arena Pharmaceuticals
  • Apex Pharma
  • Allena Pharmaceuticals
  • Aero-Chem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cyproheptadine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cyproheptadine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cyproheptadine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cyproheptadine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cyproheptadine Market Dynamics
  1. 2.1 Cyproheptadine Industry Trends
  2. 2.2 Cyproheptadine Industry Drivers
  3. 2.3 Cyproheptadine Industry Opportunities and Challenges
  4. 2.4 Cyproheptadine Industry Restraints
3 Cyproheptadine Market by Manufacturers
  1. 3.1 Global Cyproheptadine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cyproheptadine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cyproheptadine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cyproheptadine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cyproheptadine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cyproheptadine Manufacturers, Product Type & Application
  7. 3.7 Global Cyproheptadine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cyproheptadine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cyproheptadine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cyproheptadine Tier 1, Tier 2, and Tier 3
4 Cyproheptadine Market by Type
  1. 4.1 Cyproheptadine Type Introduction
  2. 4.1.1 Patent
  3. 4.1.2 Generic
  4. 4.2 Global Cyproheptadine Sales by Type
  5. 4.2.1 Global Cyproheptadine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cyproheptadine Sales by Type (2021-2032)
  7. 4.2.3 Global Cyproheptadine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Cyproheptadine Revenue by Type
  9. 4.3.1 Global Cyproheptadine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cyproheptadine Revenue by Type (2021-2032)
  11. 4.3.3 Global Cyproheptadine Revenue Market Share by Type (2021-2032)
5 Cyproheptadine Market by Application
  1. 5.1 Cyproheptadine Application Introduction
  2. 5.1.1 On-line
  3. 5.1.2 Drug Store
  4. 5.1.3 Hospital
  5. 5.2 Global Cyproheptadine Sales by Application
  6. 5.2.1 Global Cyproheptadine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cyproheptadine Sales by Application (2021-2032)
  8. 5.2.3 Global Cyproheptadine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Cyproheptadine Revenue by Application
  10. 5.3.1 Global Cyproheptadine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cyproheptadine Revenue by Application (2021-2032)
  12. 5.3.3 Global Cyproheptadine Revenue Market Share by Application (2021-2032)
6 Global Cyproheptadine Sales by Region
  1. 6.1 Global Cyproheptadine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cyproheptadine Sales by Region (2021-2032)
  3. 6.2.1 Global Cyproheptadine Sales by Region (2021-2026)
  4. 6.2.2 Global Cyproheptadine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cyproheptadine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cyproheptadine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cyproheptadine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cyproheptadine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cyproheptadine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cyproheptadine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cyproheptadine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cyproheptadine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cyproheptadine Revenue by Region
  1. 7.1 Global Cyproheptadine Revenue by Region
  2. 7.1.1 Global Cyproheptadine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cyproheptadine Revenue by Region (2021-2026)
  4. 7.1.3 Global Cyproheptadine Revenue by Region (2027-2032)
  5. 7.1.4 Global Cyproheptadine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cyproheptadine Revenue (2021-2032)
  8. 7.2.2 North America Cyproheptadine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cyproheptadine Revenue (2021-2032)
  11. 7.3.2 Europe Cyproheptadine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cyproheptadine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cyproheptadine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cyproheptadine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cyproheptadine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 MSD
  2. 8.1.1 MSD Company Information
  3. 8.1.2 MSD Business Overview
  4. 8.1.3 MSD Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 MSD Cyproheptadine Product Portfolio
  6. 8.1.5 MSD Recent Developments
  7. 8.2 Abbott
  8. 8.2.1 Abbott Company Information
  9. 8.2.2 Abbott Business Overview
  10. 8.2.3 Abbott Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Abbott Cyproheptadine Product Portfolio
  12. 8.2.5 Abbott Recent Developments
  13. 8.3 Teva
  14. 8.3.1 Teva Company Information
  15. 8.3.2 Teva Business Overview
  16. 8.3.3 Teva Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teva Cyproheptadine Product Portfolio
  18. 8.3.5 Teva Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Cyproheptadine Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Teriak
  26. 8.5.1 Teriak Company Information
  27. 8.5.2 Teriak Business Overview
  28. 8.5.3 Teriak Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Teriak Cyproheptadine Product Portfolio
  30. 8.5.5 Teriak Recent Developments
  31. 8.6 Royal Pharma
  32. 8.6.1 Royal Pharma Company Information
  33. 8.6.2 Royal Pharma Business Overview
  34. 8.6.3 Royal Pharma Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Royal Pharma Cyproheptadine Product Portfolio
  36. 8.6.5 Royal Pharma Recent Developments
  37. 8.7 Qualipharm
  38. 8.7.1 Qualipharm Company Information
  39. 8.7.2 Qualipharm Business Overview
  40. 8.7.3 Qualipharm Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Qualipharm Cyproheptadine Product Portfolio
  42. 8.7.5 Qualipharm Recent Developments
  43. 8.8 Pharma Arte
  44. 8.8.1 Pharma Arte Company Information
  45. 8.8.2 Pharma Arte Business Overview
  46. 8.8.3 Pharma Arte Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pharma Arte Cyproheptadine Product Portfolio
  48. 8.8.5 Pharma Arte Recent Developments
  49. 8.9 Panbiotic Laboratories
  50. 8.9.1 Panbiotic Laboratories Company Information
  51. 8.9.2 Panbiotic Laboratories Business Overview
  52. 8.9.3 Panbiotic Laboratories Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Panbiotic Laboratories Cyproheptadine Product Portfolio
  54. 8.9.5 Panbiotic Laboratories Recent Developments
  55. 8.10 Nichi-Iko Pharmaceutical
  56. 8.10.1 Nichi-Iko Pharmaceutical Company Information
  57. 8.10.2 Nichi-Iko Pharmaceutical Business Overview
  58. 8.10.3 Nichi-Iko Pharmaceutical Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nichi-Iko Pharmaceutical Cyproheptadine Product Portfolio
  60. 8.10.5 Nichi-Iko Pharmaceutical Recent Developments
  61. 8.11 Medphano
  62. 8.11.1 Medphano Company Information
  63. 8.11.2 Medphano Business Overview
  64. 8.11.3 Medphano Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Medphano Cyproheptadine Product Portfolio
  66. 8.11.5 Medphano Recent Developments
  67. 8.12 Laboratoires Servier
  68. 8.12.1 Laboratoires Servier Company Information
  69. 8.12.2 Laboratoires Servier Business Overview
  70. 8.12.3 Laboratoires Servier Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Laboratoires Servier Cyproheptadine Product Portfolio
  72. 8.12.5 Laboratoires Servier Recent Developments
  73. 8.13 Kalbe
  74. 8.13.1 Kalbe Company Information
  75. 8.13.2 Kalbe Business Overview
  76. 8.13.3 Kalbe Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Kalbe Cyproheptadine Product Portfolio
  78. 8.13.5 Kalbe Recent Developments
  79. 8.14 General Pharma
  80. 8.14.1 General Pharma Company Information
  81. 8.14.2 General Pharma Business Overview
  82. 8.14.3 General Pharma Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 General Pharma Cyproheptadine Product Portfolio
  84. 8.14.5 General Pharma Recent Developments
  85. 8.15 Fu Yuan Pharmaceutical
  86. 8.15.1 Fu Yuan Pharmaceutical Company Information
  87. 8.15.2 Fu Yuan Pharmaceutical Business Overview
  88. 8.15.3 Fu Yuan Pharmaceutical Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Fu Yuan Pharmaceutical Cyproheptadine Product Portfolio
  90. 8.15.5 Fu Yuan Pharmaceutical Recent Developments
  91. 8.16 Faes Pharma
  92. 8.16.1 Faes Pharma Company Information
  93. 8.16.2 Faes Pharma Business Overview
  94. 8.16.3 Faes Pharma Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Faes Pharma Cyproheptadine Product Portfolio
  96. 8.16.5 Faes Pharma Recent Developments
  97. 8.17 Cipla Medpro South Africa
  98. 8.17.1 Cipla Medpro South Africa Company Information
  99. 8.17.2 Cipla Medpro South Africa Business Overview
  100. 8.17.3 Cipla Medpro South Africa Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Cipla Medpro South Africa Cyproheptadine Product Portfolio
  102. 8.17.5 Cipla Medpro South Africa Recent Developments
  103. 8.18 Caillon and Hamonet
  104. 8.18.1 Caillon and Hamonet Company Information
  105. 8.18.2 Caillon and Hamonet Business Overview
  106. 8.18.3 Caillon and Hamonet Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Caillon and Hamonet Cyproheptadine Product Portfolio
  108. 8.18.5 Caillon and Hamonet Recent Developments
  109. 8.19 Arena Pharmaceuticals
  110. 8.19.1 Arena Pharmaceuticals Company Information
  111. 8.19.2 Arena Pharmaceuticals Business Overview
  112. 8.19.3 Arena Pharmaceuticals Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Arena Pharmaceuticals Cyproheptadine Product Portfolio
  114. 8.19.5 Arena Pharmaceuticals Recent Developments
  115. 8.20 Apex Pharma
  116. 8.20.1 Apex Pharma Company Information
  117. 8.20.2 Apex Pharma Business Overview
  118. 8.20.3 Apex Pharma Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Apex Pharma Cyproheptadine Product Portfolio
  120. 8.20.5 Apex Pharma Recent Developments
  121. 8.21 Allena Pharmaceuticals
  122. 8.21.1 Allena Pharmaceuticals Company Information
  123. 8.21.2 Allena Pharmaceuticals Business Overview
  124. 8.21.3 Allena Pharmaceuticals Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Allena Pharmaceuticals Cyproheptadine Product Portfolio
  126. 8.21.5 Allena Pharmaceuticals Recent Developments
  127. 8.22 Aero-Chem
  128. 8.22.1 Aero-Chem Company Information
  129. 8.22.2 Aero-Chem Business Overview
  130. 8.22.3 Aero-Chem Cyproheptadine Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Aero-Chem Cyproheptadine Product Portfolio
  132. 8.22.5 Aero-Chem Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cyproheptadine Value Chain Analysis
  2. 9.1.1 Cyproheptadine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cyproheptadine Production Mode & Process
  6. 9.2 Cyproheptadine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cyproheptadine Distributors
  9. 9.2.3 Cyproheptadine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst